Mo1527 HIGH SERUM LEVELS OF INTERLEUKIN-10, MACROPHAGE COLONYSTIMULATING FACTOR AND SOLUBLE CD40L INDEPENDENTLY PREDICT 90-DAY MORTALITY IN SEVERE ...

Mo1526 ANAKINRA + ZINC TREATMENT IN PATIENTS WITH SEVERE ALCOHOLASSOCIATED HEPATITIS REDUCED SERUM CCL11 AND G-CSF IN A 28 DAY PERIOD: A MULTICENTER SERUM ...

Mo1503 GLOBAL PREVALENCE, CLINICAL CHARACTERISTICS, SURVEILLANCE, TREATMENT ALLOCATION, AND OUTCOMES OF ALCOHOL-ASSOCIATED HEPATOCELLULAR CARCINOMA: ...

Mo1546 INCREASING TRENDS ON ALCOHOL-ASSOCIATED LIVER DISEASE AND METABOLIC-ASSOCIATED STEATOHEPATITIS IN SPECIFIC CANDIDATE GROUPS AMONG LIVER TRANSPLANT ...

Mo1518 DETERMINANTS OF RISKS ASSOCIATED WITH ALCOHOL-ASSOCIATED HEPATITIS OR PANCREATITIS: A COMPREHENSIVE ANALYSIS OF THE ALL OF US COHORT

An Alcohol-Associated Rash

INTRODUCTION Alcohol-associated liver disease (ALD) is a leading cause of preventable liver-related morbidity and mortality worldwide, including ...